Skip to main content
Equibles
MYO logo

MYO · Myomo, Inc. · Metrics

Track MYO — free

Use MYO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MYO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.21 +0.02 (+1.68%) At close · Nov 6 Play latest call Q2 2026 earnings call transcript
Rebalance outlook locked
Market Cap
$48.32M
Shares
39.61M
Volume · Nov 6 184.68K Avg daily vol (3M) 430.14K

MYO metrics

84 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$1.21
Market cap
$48.32M

Price action

23 metrics
Price change (1W)
-8.5%
Price change (30D)
-17.9%
Price change (3M)
-9.2%
Price change (6M)
+36.5%
Price change (YTD)
+30.8%
Price change (1Y)
+37.9%
Trailing year
Price change (5Y)
-88.6%
52-week high
$1.86
52-week low
$0.64
Change from 52-week high
-36.0%
Change from 52-week low
+85.9%
Annualized volatility
95.1%
Annualized volatility (3M)
103.4%
Implied volatility (30D)
—
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
2.1
RSI (14D)
41.3
Price vs SMA 50
-14.6%
Price vs SMA 200
+9.8%
Avg volume (3M)
459,857
Relative volume
0.6
Average dollar volume
$679,534

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
39.61M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
1.1×
reciprocal yield 93.2%
EV / EBITDA
—
EV / EBIT
—
P / sales
1.1×
reciprocal yield 89.5%
P / book
8.3
reciprocal yield 12.1%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-30.0%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
2.8×
reciprocal yield 35.9%
EV / revenue historical average (5Y)
2.1×
reciprocal yield 48.3%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-11-09
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
68.4%
Operating margin
-27.1%
Trailing 12 months
Net margin
-33.5%
Gross profit (TTM)
$29.57M
Operating profit (TTM)
−$11.70M
Net income (TTM)
−$14.51M
Trailing 12 months
Diluted EPS (TTM)
$-0.34
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$1.02
Gross profit per diluted share (TTM)
$0.70
Operating profit per diluted share (TTM)
$-0.28
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$-0.34
Operating cash flow per diluted share (TTM)
$-0.17
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
$0.15
Stock compensation per diluted share (TTM)
$0.07
Book value per share
$0.30

Growth

11 metrics
Revenue growth YoY
+21.3%
Year over year
Net income growth YoY
—
Revenue (TTM)
$43.26M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+2.7%
Year over year · more shares
Revenue CAGR (3Y)
+38.1%
Revenue CAGR (5Y)
+40.1%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-248.9%
Return on assets
-41.0%
Debt / equity
2.0
Current ratio
2.3
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
2.0
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$1.92M
Latest balance sheet
Cash & equivalents
$11.22M
Total assets
$35.34M
Total debt
$11.53M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$7.11M
Capital expenditures (TTM)
$1.21M
R&D (TTM)
$6.50M
SG&A (TTM)
$18.78M
Stock compensation (TTM)
$2.79M
R&D / revenue
15.0%
Stock compensation / revenue
6.4%

Ownership (13F)

9 metrics
13F filers
79
13F filer change QoQ
-3
Institutional ownership
31.0%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
10.7%
Private-fund adviser ownership
6.2%
Active holders' share change QoQ
+25.2%
Holder tenure
6.8
Price vs estimated holder cost
-35.7%

Ownership (registered funds)

1 metrics
Index-fund ownership
6.8%

Short interest

3 metrics
Short interest
2.7%
Latest settlement · 3.9 days to cover
Days to cover
3.9d
Short-squeeze score
57 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$71,615
Insider-sentiment score
31 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1369290 CUSIP 62857J201 13F (30d) 25 filings 23 filers Visit website Investor relations